Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates - II. A sequential lysis protocol for the analysis of tyrosine phosphorylation-dependent signalling

被引:20
作者
Gilbert, C
Rollet-Labelle, E
Naccache, PH
机构
[1] CHUL, Ctr Rech Rhumatol & Immunol, CIHR Grp Mol Mechanisms Inflammat, Ste Foy, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Med, Dept Med, Ste Foy, PQ, Canada
基金
加拿大健康研究院;
关键词
Cbl; CD32; detergent insolubility; Fc gamma receptors; fMet-Leu-Phe; GM-CSF; kinase activity; Lyn; monosodium urate crystals; neutrophil phagocytosis; signal transduction; Syk; tyrosine phosphorylation;
D O I
10.1016/S0022-1759(01)00553-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In stimulated neutrophils, the majority of tyrosine phosphorylated proteins are concentrated in Triton X-100 or NP-40 insoluble fractions. Most immunobiochemical studies, whose objective is to study the functional relevance of tyrosine phosphorylation are, however, performed using the supernatants of cells lysed in non-ionic detergent-containing buffers (RIPA lysis buffers). This observation prompted us to develop an alternative lysis protocol. We established a procedure involving the sequential lysis of neutrophils in buffers of increasing tonicities that not only preserved and solubilized tyrosine phosphorylated proteins but also retained their enzymatic activities. The sequential lysis of neutrophils in hypotonic, isotonic and hypertonic buffers containing non-ionic detergents resulted in the solubilisation of a significant fraction of tyrosine phosphorylated proteins. Furthermore, we observed that in monosodium urate crystals-stimulated neutrophils, Lyn activity was enhanced in the soluble fraction recovered from the hypertonic fraction, but not from that of the first hypotonic lysis. The distribution of tyrosine phosphorylated proteins between the NP-40 soluble and insoluble fractions was both substrate- and agonist-dependent. In neutrophils stimulated with fMet-Leu-Phe, MSU crystals or by CD32 ligation, the tyrosine phosphorylated proteins were mostly insoluble. On the other hand, in GM-CSF-treated cells, the phosphoproteins were more equally distributed between the two fractions. The results of this study provide a new experimental procedure for the investigation of tyrosine phosphorylation pathways in activated human neutrophils which may also be applicable to other cell types. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:85 / 101
页数:17
相关论文
共 54 条
[1]   Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils - Selective activation of Jak2, Stat3, and Stat5B [J].
Al-Shami, A ;
Mahanna, W ;
Naccache, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :1058-1063
[2]   Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils .1. Tyrosine phosphorylation-dependent stimulation of phosphatidylinositol 3-kinase and inhibition by phorbol esters [J].
AlShami, A ;
Bourgoin, SG ;
Naccache, PH .
BLOOD, 1997, 89 (03) :1035-1044
[3]   Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates [J].
AlShami, A ;
Gilbert, C ;
Barabe, F ;
Gaudry, M ;
Naccache, PH .
JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 202 (02) :183-191
[4]  
ASAHI M, 1993, J BIOL CHEM, V268, P23334
[5]   Crystal-induced neutrophil activation VI.: Involvement of FcγRIIIB (CD16) and CD11b in response to inflammatory microcrystals [J].
Barabé, F ;
Gilbert, C ;
Liao, N ;
Bourgoin, SG ;
Naccache, PH .
FASEB JOURNAL, 1998, 12 (02) :209-220
[6]   Granules of the human neutrophilic polymorphonuclear leukocyte [J].
Borregaard, N ;
Cowland, JB .
BLOOD, 1997, 89 (10) :3503-3521
[7]   Regulation of Src homology 2-containing tyrosine phosphatase 1 during activation of human neutrophils - Role of protein kinase C [J].
Brumell, JH ;
Chan, CK ;
Butler, J ;
Borregaard, N ;
Siminovitch, KA ;
Grinstein, S ;
Downey, GP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :875-882
[8]  
CASSATELLA MA, 1996, CYTOKINES PRODUCED P
[9]  
Cui Y, 1996, BLOOD, V87, P341
[10]  
CUI Y, 1994, J IMMUNOL, V152, P5420